Analyst Vijay Kumar names the stocks as his top picks among medical device companies as Wall Street heads into earnings season.
The heart-implant manufacturer is down some 4% over two days, but is up 128% year to date.
Jim Cramer says the tech titans are leading the way, but out side of the tech sector, very few stocks are following.
Omar Ishrak, chairman and CEO of Medtronic, tells Jim Cramer about advances in cardiac and metabolic technologies.
Tech and retail gains aren't enough to lead markets to new highs.
The crash of oil will only accelerate the move.
Charts say the medical-devices firm should have a price target 16% above current levels, but one indicator fails to confirm that.
All of these stocks are standard go-to names when inflation is peaking.
Stocks fall Thursday after Donald Trump calls off a summit meeting planned for next month with North Korea leader Kim Jong Un.
Relief is on the way, and there's an inexpensive beneficiary out in California.
U.S. stock futures turn lower; the Trump administration threatens to impose new tariffs on automobile imports; Deutsche Bank to cut 7,000 jobs.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BP, BREW, BZUN, CHCT, CHS, MDT, MOH, PENN, SDPI, SHOP, TSCO, WP, ZX Downgrades: BMCH, LAWS, PBFX, SRT, TRI Initiations: PCSB Read on to get TheStreet Quant Ratings' detailed report:
The appointment of Mike Weinstein as senior vice president of strategy has sparked the question of what the med tech firm should do to unlock shareholder value.
Medical bills can cost hundreds of thousands of dollars in retirement, so it's important to have steady income coming in. Try these good dividend-paying stocks on for size.
We continue to view Abbott as our favorite healthcare play.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CXO, GOGL, LBRDA, LBRDK Downgrades: ANIP, CTB, HVT, HVT.A, MANH, MDT, MSA, PMBC, TAYD, TGH, UBP Initiations: CJ, FTI, VREX Read on to get TheStreet Quant Ratings' detailed report:
Large-cap healthcare stocks, especially those in the medical technology sector, are one of the biggest losers in the recent market selloff.
If you are looking for the best dividend stocks out there, look no further than these top dividend aristocrats.
Healthcare executives meeting at JP Morgan Conference agree that new tax reform is good, but how it will impact the sector is not yet entirely clear.
A look at stocks seeing bullish and bearish reversal characteristics over the past week.
After two weeks of losses, the three benchmark indexes come out swinging on Tuesday. Tech and healthcare strength bolstered Wall Street gains.
After two weeks of losses, the three benchmark indexes came out swinging on Tuesday. Tech and healthcare strength bolstered Wall Street gains.
The Health Care SPDR ETF (XLV) was rising nearly 1% in afternoon trading on Tuesday, boosted in part, by solid results from medical equipment company Medtronic.
Many investors don't seem too impressed by the constantly better-than-expected earnings results from companies this quarter. But those results make it hard to be bearish, Jim Cramer says.
Companies aim to improve disease management.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer was pleased with Medtronic's latest quarterly earnings.
This pullback is a textbook example of why you can't take your cue only from the action, says Jim Cramer.
